Dementia diagnosis: why patients can’t wait for the future
The government’s new vision for dementia diagnosis is ambitious: by 2029, more than 92 per cent of patients could receive a diagnosis within 18 weeks of referral, up from fewer than half today.
Getting classification right: Why remote monitoring safety depends on using the right level of medical device assurance
Remote monitoring has become an essential component of virtual wards and community-based care. As adoption accelerates, understanding medical-device classification is not a legal technicality, but a matter of clinical safety, governance and system integrity.
Beyond the attack count: Turning shared decision making into a reality in HAE care
For individuals living with hereditary angioedema (HAE) in the UK, their journey often begins with uncertainty, misdiagnosis and fragmented care.
Clinically led, patient first: Redefining specialist care in dermatology
When lead clinician Andrew Morris reflects on the origins of the Sussex Community Dermatology Service (SCDS), one principle has guided every decision: putting the patient at the centre.
Fostering co-production and tackling racism will build an NHS fit for all
The healthcare system’s current participation and co-production practice with diverse and marginalised communities remains, at best, extremely variable. At its worst, it can be actively harmful in its exclusion of some of the most marginalised voices in society.
Shaping the future of respiratory care together
From addressing critical challenges to shaping innovative solutions: GSK’s medical head, general medicines, UK, Aruni Mulgirigama, shares her perspective on the future of respiratory care
Spotlighting the hidden challenges facing people living with blood cancer
This content has been developed and funded by Pfizer UK. Cancer is one of the biggest challenges of our lifetime. At Pfizer UK, we are determined to use our voice and position at the forefront of oncology care to help improve outcomes for cancer care and ensure no patient gets ...
A collaborative, prevention-first approach to tackling chronic kidney disease
This advertorial has been co-written and co-developed as part of the SPOT CKD collaborative working project between Boehringer Ingelheim, Hampshire and Isle of Wight Integrated Care Board, Health Innovation North East and North Cumbria, and the North East and North Cumbria ICB. The article has been funded by Boehringer Ingelheim.
Transforming asthma care: Driving evidence-based practice in Bedfordshire, Luton and Milton Keynes ICB
Asthma affects 7.2 million people in the UK, with annual costs to the NHS estimated at £3bn.1,2
Tackling health inequalities in a digital NHS: Making inclusion the national priority
As the NHS accelerates its digital transformation, the ambition is clear: the NHS App is set to become the digital front door for healthcare in England.